R. Kent Jr McGaughy - Jan 3, 2022 Form 4 Insider Report for REATA PHARMACEUTICALS INC (RETA)

Role
Director, 10%+ Owner
Signature
/s/ R. Kent McGaughy, Jr.
Stock symbol
RETA
Transactions as of
Jan 3, 2022
Transactions value $
$6,440
Form type
4
Date filed
1/5/2022, 04:22 PM
Previous filing
Oct 19, 2021
Next filing
Mar 17, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RETA Stock Option (right to buy) Award $6.44K +399 $16.14 399 Jan 3, 2022 Class A common stock 399 $27.32 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest in 2 equal installments on March 10, 2022 and June 10, 2022, subject to continued service through each vesting date.
F2 This option was issued to the reporting person pursuant to the Reata Non-Employee Director Compensation Policy in lieu of director fees of $6,456.